少数族裔成年患者参与临床试验的促进与阻碍因素:系统综述
本系统综述检索四个数据库,纳入2017年1月1日至2022年10月1日发表的43篇文章,其中36篇来自美国、20篇涉及肿瘤试验、39篇报告患者视角信息,旨在识别少数族裔参与临床试验的阻碍与促进因素。阻碍包括少数族裔研究者缺乏、少数族裔地区试验经费不足及研究人员对目标群体和招募策略认识不足;文章建议使用患者导航员或社区联络角色、翻译研究材料及利用虚拟技术减少长途旅行。
要点
- 阻碍包括缺乏少数族裔研究者、少数族裔地区经费不足及研究人员招募知识不足。
- 文章高度推荐使用患者导航员或社区联络角色支持患者完成招募过程。
- 将研究材料翻译为多种语言并让多元社区参与健康教育材料开发有益。
核心结论
- 确保少数族裔在临床试验中的代表性对开发具有可推广疗效的疗法至关重要。
- 在扩大种族群体覆盖和加强教育资源方面已取得进展,但仍需深入研究阻碍多元参与者招募的障碍,尤其是在相关研究稀缺的美国以外地区。
研究设计与样本
- 系统文献综述,系统检索Web of Science、PubMed、CINAHL Plus和Cochrane Library四个数据库。
- 检索不受语言或研究地点限制,但发表时间限定为2017年1月1日至2022年10月1日。
- 纳入讨论或概述少数族裔参与临床试验以及包容性招募和参与程序的研究,共纳入43篇文章。
主要发现
- 43篇文章中,36篇来自美国,20篇报告肿瘤试验,39篇报告患者视角信息。
- 阻碍包括缺乏实施和开展临床研究的少数族裔研究者。
- 阻碍包括服务少数族裔人群的地理区域临床试验努力经费不足。
- 阻碍包括研究人员对哪些代表性不足群体应作为招募目标以及采用何种策略接触他们缺乏认识和培训。
临床怎么用
- 纳入文章提出多项建议以解决这些阻碍,其中使用患者导航员或社区联络角色被高度推荐为支持患者完成研究招募过程的方式。
- 文章强调将研究材料和干预措施翻译为多种语言以及让多元社区积极参与健康教育材料开发的益处。
- 利用技术解决社会经济障碍,例如使用虚拟方法避免长途旅行,也可能有助于改善试验多样性。
局限性
- 相关研究在美国以外地区稀缺,仍需深入研究阻碍多元参与者招募的障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical trials are essential to the development of healthcare innovations that advance life expectancy and improve quality of life. However, there exists a pronounced disparity in ethnic representation among trial participants. This imbalance, particularly in relation to minority ethnic groups, can lead to a limited understanding of how therapies affect diverse populations. The present systematic literature review (SLR) aims to identify the factors that both hinder and facilitate the participation of minority ethnic groups in clinical trials. METHODS: This review involved a systematic search of keywords across four databases: Web of Science, PubMed, CINAHL Plus and The Cochrane Library. The review was not restricted by language or study site; however, the date of publication was limited between 1st January 2017 and 1st October 2022. Studies discussing or outlining the involvement of minority ethnic groups in clinical trials, and those outlining inclusive recruitment and participation procedures were targeted. RESULTS: A total of 43 articles were included in the review. Of these, 36 articles were from the United States (US), 20 articles reported on oncology trials and 39 articles reported information from the patient's perspective. Reported barriers included a lack of researchers from minority ethnic groups implementing and conducting clinical research, inadequate funding for clinical trial efforts in geographical areas serving minority populations and a lack of awareness and education among research staff regarding which underrepresented groups to target for recruitment and the strategies to employ in reaching out to them. Several recommendations were suggested by the articles included in the review to address these barriers. Prominently, the use of patient navigators or community liaison roles was highly recommended as a way of supporting patients through the research recruitment process. The articles also highlighted the benefits of translating study materials and interventions into multiple languages and actively involving diverse communities in the development of health education materials. Lastly, leveraging technologies to address socioeconomic barriers, such as the use of virtual approaches to avoid lengthy travel, may also help to improve diversity in trials. CONCLUSIONS: Ensuring representation of minority ethnic groups in clinical trials is critical to developing therapies with generalisable efficacies. While progress has been made in enhancing outreach of wider racial groups and fortifying educational resources, there remains a pressing need to delve deeper into the obstacles impeding the recruitment of a diverse participant base, particularly in regions outside the US, where relevant studies are scarce. REGISTRATION: The review protocol was registered on PROSPERO (CRD42022368106) (1).
引用
- Alarcón Garavito GA, Gilchrist K, Ciurtin C, et al. Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review. Trials. 2025. PMID: 39984940. doi:10.1186/s13063-025-08769-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。